DexCom had five patents in mobile during Q2 2024. DexCom Inc’s patents filed in Q2 2024 focus on systems and methods for creating customizable graphical displays of analyte data and health information. These displays are based on a self-referential dataset that can be modified to highlight specific features in the host’s analyte data. GlobalData’s report on DexCom gives a 360-degree view of the company including its patenting strategy. Buy the report here.
DexCom had no grants in mobile as a theme in Q2 2024.
Recent Patents
Application: Systems and methods for health data visualization and user support tools for continuous glucose monitoring (Patent ID: US20240197264A1)
The patent filed by DexCom Inc. discloses systems and methods for generating graphical displays of analyte data and health information. These graphical displays are based on a self-referential dataset that can be modified based on identified portions of the data, allowing for the indication of features in the analyte data of a host. The system includes a continuous analyte sensor, sensor electronics module, and wireless transmitters to transmit analyte data directly to smartwatch and smartphone display devices, each generating visual representations of the data with or without additional processing.
The analyte monitoring system described in the patent enables the measurement of analyte concentration in a host, generation of analyte data, and transmission of this data to smartwatch and smartphone display devices for visualization. The method involves receiving electrical current from the continuous analyte sensor, generating analyte data, and transmitting it wirelessly to the display devices. The system allows for the generation of graphical user interfaces on the smartwatch and smartphone to display visual representations of the analyte data, with the option for additional processing by the devices. Different formats and contents of data packages can be transmitted to each display device, and alarms can be generated based on the analyte data in a predetermined sequential order or simultaneously on both devices.
To know more about GlobalData’s detailed insights on DexCom, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.